Patent · US Active

Treatment of ischemic events

US8216998B2 · kind B2 · utility

0Cited by
105References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2006
Grant dateJul 10, 2012
Priority date
Expiry dateFeb 27, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the treatment of an ischemic event such as a stroke or myocardial infarction. The invention provides a method for modulating an ischemic event in a subject comprising providing the subject with a gene-regulatory peptide or functional analogue thereof. Furthermore, the invention provides use of an NF-κB-down-regulating peptide or functional analogue thereof for the production of a pharmaceutical composition for the treatment of reperfusion injury occurring after an ischemic event in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.